Related Experiment Video
Updated: Sep 25, 2026
Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder
Claudia M Szobot1, Carla Ketzer, Renato D Cunha
1Department of Psychiatry, Federal University of Rio Grande do Sul, Brazil.
Abstract:
Methylphenidate (MPH) is the most commonly prescribed treatment for attention-deficit/hyperactivity disorder (ADHD). The therapeutic mechanisms of MPH are not, however, fully understood. We studied the effects of MPH on brain activity in male children and adolescents with ADHD, using the blood flow radiotracer technetium-99m ethyl cysteinate dimer ((99m)Tc-ECD) and single-photon emission tomography (SPET). The study was randomized, double blind, and placebo controlled (MPH group, n=19; placebo group, n=17), Radiotracer was administered during the performance of the Continuous Performance Test and before and after 4 days of MPH treatment. Statistical parametric mapping (SPM99) analysis showed a significant reduction in regional cerebral blood flow in the left parietal region in the MPH group compared with the placebo group (P<0.05, corrected for multiple comparisons). Our findings suggest that the posterior attentional system, which includes the parietal cortex, may have a role in the mediation of the therapeutic effects of MPH in ADHD.
Insights
Methylphenidate (MPH) treatment for attention-deficit/hyperactivity disorder (ADHD) may work by affecting brain activity. This study found reduced blood flow in the left parietal region in children with ADHD after MPH treatment.
Area of Science:
- Neuroscience
- Radiopharmacology
Background:
- Methylphenidate (MPH) is a primary pharmacological treatment for attention-deficit/hyperactivity disorder (ADHD).
- The precise therapeutic mechanisms of MPH remain incompletely elucidated.
- Understanding MPH's effects on brain activity is crucial for optimizing ADHD treatment.
Purpose of the Study:
- To investigate the impact of Methylphenidate (MPH) on regional cerebral blood flow (rCBF) in male children and adolescents diagnosed with ADHD.
- To explore the neural correlates of MPH's therapeutic effects using advanced neuroimaging techniques.
Main Methods:
- A randomized, double-blind, placebo-controlled study involving 36 male participants with ADHD (19 MPH group, 17 placebo group).
- Utilized technetium-99m ethyl cysteinate dimer ((99m)Tc-ECD) and single-photon emission tomography (SPET) to measure rCBF.
- Radiotracer administration occurred during the Continuous Performance Test (CPT) before and after a 4-day MPH treatment period.
Main Results:
- Statistical Parametric Mapping (SPM99) analysis revealed a significant reduction in rCBF within the left parietal region in the MPH group compared to the placebo group (P<0.05, corrected).
- This finding suggests a specific neurobiological effect of MPH on attentional networks.
Conclusions:
- The results indicate that the posterior attentional system, encompassing the parietal cortex, plays a significant role in mediating the therapeutic effects of Methylphenidate in ADHD.
- These findings contribute to a deeper understanding of MPH's mechanism of action in ADHD treatment.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
